Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Mexican and U.S. scientists: Partners.

Science (New York, N.Y.)

Lazcano A, Ortega AO, Armendariz S.
PMID: 28302816
Science. 2017 Mar 17;355(6330):1139. doi: 10.1126/science.aan0569. Epub 2017 Mar 16.

No abstract available.

Cite
Lazcano A, Ortega AO, Armendariz S. Mexican and U.S. scientists: Partners. Science. 2017;355(6330):1139doi: 10.1126/science.aan0569.
Lazcano, A., Ortega, A. O., & Armendariz, S. (2017). Mexican and U.S. scientists: Partners. Science (New York, N.Y.), 355(6330), 1139. https://doi.org/10.1126/science.aan0569
Lazcano, Antonio, et al. "Mexican and U.S. scientists: Partners." Science (New York, N.Y.) vol. 355,6330 (2017): 1139. doi: https://doi.org/10.1126/science.aan0569
Lazcano A, Ortega AO, Armendariz S. Mexican and U.S. scientists: Partners. Science. 2017 Mar 17;355(6330):1139. doi: 10.1126/science.aan0569. Epub 2017 Mar 16. PMID: 28302816.
Copy Download .nbib Format: NLM
SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Gettings JR, Gold JAW, Kimball A, Forsberg K, Scott C, Uehara A, Tong S, Hast M, Swanson MR, Morris E, Oraka E, Almendares O, Thomas ES, Mehari L, McCloud J, Roberts G, Crosby D, Balajee A, Burnett E, Chancey RJ, Cook P, Donadel M, Espinosa C, Evans ME, Fleming-Dutra KE, Forero C, Kukielka EA, Li Y, Marcet PL, Mitruka K, Nakayama JY, Nakazawa Y, O'Hegarty M, Pratt C, Rice ME, Rodriguez Stewart RM, Sabogal R, Sanchez E, Velasco-Villa A, Weng MK, Zhang J, Rivera G, Parrott T, Franklin R, Memark J, Drenzek C, Hall AJ, Kirking HL, Tate JE, Vallabhaneni S.
PMID: 33864375
Clin Infect Dis. 2021 Apr 17; doi: 10.1093/cid/ciab332. Epub 2021 Apr 17.

BACKGROUND: To inform prevention strategies, we assessed the extent of SARS-CoV-2 transmission and settings in which transmission occurred in a Georgia public school district.METHODS: During December 1, 2020-January 22, 2021, SARS-CoV-2-infected index cases and their close contacts in schools...

Cite
Gettings JR, Gold JAW, Kimball A, et al. SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab332.
Gettings, J. R., Gold, J. A. W., Kimball, A., Forsberg, K., Scott, C., Uehara, A., Tong, S., Hast, M., Swanson, M. R., Morris, E., Oraka, E., Almendares, O., Thomas, E. S., Mehari, L., McCloud, J., Roberts, G., Crosby, D., Balajee, A., Burnett, E., Chancey, R. J., Cook, P., Donadel, M., Espinosa, C., Evans, M. E., Fleming-Dutra, K. E., Forero, C., Kukielka, E. A., Li, Y., Marcet, P. L., Mitruka, K., Nakayama, J. Y., Nakazawa, Y., O'Hegarty, M., Pratt, C., Rice, M. E., Rodriguez Stewart, R. M., Sabogal, R., Sanchez, E., Velasco-Villa, A., Weng, M. K., Zhang, J., Rivera, G., Parrott, T., Franklin, R., Memark, J., Drenzek, C., Hall, A. J., Kirking, H. L., Tate, J. E., & Vallabhaneni, S. (2021). SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab332
Gettings, Jenna R, et al. "SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab332
Gettings JR, Gold JAW, Kimball A, Forsberg K, Scott C, Uehara A, Tong S, Hast M, Swanson MR, Morris E, Oraka E, Almendares O, Thomas ES, Mehari L, McCloud J, Roberts G, Crosby D, Balajee A, Burnett E, Chancey RJ, Cook P, Donadel M, Espinosa C, Evans ME, Fleming-Dutra KE, Forero C, Kukielka EA, Li Y, Marcet PL, Mitruka K, Nakayama JY, Nakazawa Y, O'Hegarty M, Pratt C, Rice ME, Rodriguez Stewart RM, Sabogal R, Sanchez E, Velasco-Villa A, Weng MK, Zhang J, Rivera G, Parrott T, Franklin R, Memark J, Drenzek C, Hall AJ, Kirking HL, Tate JE, Vallabhaneni S. SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021. Clin Infect Dis. 2021 Apr 17; doi: 10.1093/cid/ciab332. Epub 2021 Apr 17. PMID: 33864375; PMCID: PMC8083290.
Copy Download .nbib Format: NLM
Development and validation of the juvenile spondyloarthritis disease flare (JSpAflare) measure: Ascertaining flare in patients with inactive disease.

Arthritis care & research

Weiss PF, Brandon TG, Ryan ME, Treemarcki EB, Armendariz S, Wright TB, Godiwala C, Stoll ML, Xiao R, Lovell D.
PMID: 34363343
Arthritis Care Res (Hoboken). 2021 Aug 07; doi: 10.1002/acr.24763. Epub 2021 Aug 07.

OBJECTIVE: Our objective was to develop and validate a composite disease flare definition for juvenile spondyloarthritis that would closely approximate the clinical decision made to reinitiate/not reinitiate systemic therapy after therapy de-escalation.METHODS: Retrospective chart reviews of children with spondyloarthritis...

Cite
Weiss PF, Brandon TG, Ryan ME, et al. Development and validation of the juvenile spondyloarthritis disease flare (JSpAflare) measure: Ascertaining flare in patients with inactive disease. Arthritis Care Res (Hoboken). 2021;doi: 10.1002/acr.24763.
Weiss, P. F., Brandon, T. G., Ryan, M. E., Treemarcki, E. B., Armendariz, S., Wright, T. B., Godiwala, C., Stoll, M. L., Xiao, R., & Lovell, D. (2021). Development and validation of the juvenile spondyloarthritis disease flare (JSpAflare) measure: Ascertaining flare in patients with inactive disease. Arthritis care & research, . https://doi.org/10.1002/acr.24763
Weiss, P F, et al. "Development and validation of the juvenile spondyloarthritis disease flare (JSpAflare) measure: Ascertaining flare in patients with inactive disease." Arthritis care & research vol. (2021). doi: https://doi.org/10.1002/acr.24763
Weiss PF, Brandon TG, Ryan ME, Treemarcki EB, Armendariz S, Wright TB, Godiwala C, Stoll ML, Xiao R, Lovell D. Development and validation of the juvenile spondyloarthritis disease flare (JSpAflare) measure: Ascertaining flare in patients with inactive disease. Arthritis Care Res (Hoboken). 2021 Aug 07; doi: 10.1002/acr.24763. Epub 2021 Aug 07. PMID: 34363343.
Copy Download .nbib Format: NLM
[No title available]

Salud publica de Mexico

Hubert C, Villalobos A, Armendares N, Vázquez-Salas A.
PMID: 34098596
Salud Publica Mex. 2021 May 20; doi: 10.21149/12246. Epub 2021 May 20.

Objetivo. Determinar el estado de salud, bienestar, desa-rrollo infantil temprano (DIT) de los niños y niñas menores de cinco años y su asociación con la edad de la madre. Material y métodos. Utilizando la Encuesta Nacional de Niños, Niñas...

Cite
Hubert C, Villalobos A, Armendares N, et al. Diferenciales en desarrollo infantil temprano por edad de la madre, Encuesta Nacional de Niños, Niñas y Mujeres 2015. . Salud Publica Mex. 2021;doi: 10.21149/12246.
Hubert, C., Villalobos, A., Armendares, N., & Vázquez-Salas, A. (2021). Diferenciales en desarrollo infantil temprano por edad de la madre, Encuesta Nacional de Niños, Niñas y Mujeres 2015. . Salud publica de Mexico, . https://doi.org/10.21149/12246
Hubert, Celia, et al. "Diferenciales en desarrollo infantil temprano por edad de la madre, Encuesta Nacional de Niños, Niñas y Mujeres 2015." . Salud publica de Mexico vol. (2021). doi: https://doi.org/10.21149/12246
Hubert C, Villalobos A, Armendares N, Vázquez-Salas A. Diferenciales en desarrollo infantil temprano por edad de la madre, Encuesta Nacional de Niños, Niñas y Mujeres 2015. . Salud Publica Mex. 2021 May 20; doi: 10.21149/12246. Epub 2021 May 20. Spanish. PMID: 34098596.
Copy Download .nbib Format: NLM
Performance characteristics of the Abbott BinaxNOW SARS-CoV-2 antigen test in comparison to real-time RT-PCR and viral culture in community testing sites during November 2020.

Journal of clinical microbiology

Almendares O, Prince-Guerra JL, Nolen LD, Gunn JKL, Dale AP, Buono SA, Deutsch-Feldman M, Suppiah S, Hao L, Zeng Y, Stevens VA, Knipe K, Pompey J, Atherstone C, Bui DP, Powell T, Tamin A, Harcourt JL, Petway M, Bohannon C, Folster JM, MacNeil A, Salerno R, Kuhnert-Tallman W, Tate JE, Thornburg N, Kirking HL, Sheiban K, Kudrna J, Cullen T, Komatsu KK, Villanueva JM, Rose DA, Neatherlin JC, Anderson M, Rota PA, Honein MA, Bower WA.
PMID: 34705535
J Clin Microbiol. 2021 Oct 27;JCM0174221. doi: 10.1128/JCM.01742-21. Epub 2021 Oct 27.

Point-of-care antigen tests are an important tool for SARS-CoV-2 detection. Antigen tests are less sensitive than real-time reverse-transcriptase PCR (rRT-PCR). Data on the performance of the BinaxNOW antigen test compared to rRT-PCR and viral culture by symptom and known...

Cite
Almendares O, Prince-Guerra JL, Nolen LD, et al. Performance characteristics of the Abbott BinaxNOW SARS-CoV-2 antigen test in comparison to real-time RT-PCR and viral culture in community testing sites during November 2020. J Clin Microbiol. 2021;JCM0174221doi: 10.1128/JCM.01742-21.
Almendares, O., Prince-Guerra, J. L., Nolen, L. D., Gunn, J. K. L., Dale, A. P., Buono, S. A., Deutsch-Feldman, M., Suppiah, S., Hao, L., Zeng, Y., Stevens, V. A., Knipe, K., Pompey, J., Atherstone, C., Bui, D. P., Powell, T., Tamin, A., Harcourt, J. L., Petway, M., Bohannon, C., Folster, J. M., MacNeil, A., Salerno, R., Kuhnert-Tallman, W., Tate, J. E., Thornburg, N., Kirking, H. L., Sheiban, K., Kudrna, J., Cullen, T., Komatsu, K. K., Villanueva, J. M., Rose, D. A., Neatherlin, J. C., Anderson, M., Rota, P. A., Honein, M. A., Bower, W. A. (2021). Performance characteristics of the Abbott BinaxNOW SARS-CoV-2 antigen test in comparison to real-time RT-PCR and viral culture in community testing sites during November 2020. Journal of clinical microbiology, JCM0174221. https://doi.org/10.1128/JCM.01742-21
Almendares, Olivia, et al. "Performance characteristics of the Abbott BinaxNOW SARS-CoV-2 antigen test in comparison to real-time RT-PCR and viral culture in community testing sites during November 2020." Journal of clinical microbiology vol. (2021): JCM0174221. doi: https://doi.org/10.1128/JCM.01742-21
Almendares O, Prince-Guerra JL, Nolen LD, Gunn JKL, Dale AP, Buono SA, Deutsch-Feldman M, Suppiah S, Hao L, Zeng Y, Stevens VA, Knipe K, Pompey J, Atherstone C, Bui DP, Powell T, Tamin A, Harcourt JL, Petway M, Bohannon C, Folster JM, MacNeil A, Salerno R, Kuhnert-Tallman W, Tate JE, Thornburg N, Kirking HL, Sheiban K, Kudrna J, Cullen T, Komatsu KK, Villanueva JM, Rose DA, Neatherlin JC, Anderson M, Rota PA, Honein MA, Bower WA. Performance characteristics of the Abbott BinaxNOW SARS-CoV-2 antigen test in comparison to real-time RT-PCR and viral culture in community testing sites during November 2020. J Clin Microbiol. 2021 Oct 27;JCM0174221. doi: 10.1128/JCM.01742-21. Epub 2021 Oct 27. PMID: 34705535.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries